CMPS
Closed
Compass Pathways plc
3.16
+0.36 (+12.86%)
Last Update: 01 Jul 2025 23:23:00
Yesterday: 2.8
Day's Range: 2.82 - 3.2393
Send
sign up or login to leave a comment!
When Written:
9.93
Compass Pathways Plc is a mental health care company that specializes in developing and delivering innovative therapies for patients suffering from treatment-resistant depression (TRD). The company's flagship product is a psilocybin-based therapy, which is a psychedelic compound found in magic mushrooms. Compass Pathways is focused on conducting clinical trials and research to demonstrate the safety and efficacy of psilocybin-based therapies for TRD. The company was founded in 2016 and is headquartered in London, UK. It went public on the NASDAQ stock exchange in September 2020, raising $146.6 million in its initial public offering.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








